tiprankstipranks
Trending News
More News >
Fortress Biotech (FBIO)
NASDAQ:FBIO
US Market

Fortress Biotech (FBIO) Financial Statements

Compare
1,410 Followers

Fortress Biotech Financial Overview

Fortress Biotech's market cap is currently $52.04M. The company's EPS TTM is $; its P/E ratio is ―; Fortress Biotech is scheduled to report earnings on May 15, 2025, and the estimated EPS forecast is $-0.36. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 57.67M$ 84.51M$ 75.74M$ 68.79M$ 45.60M
Gross Profit$ 36.80M$ 57.85M$ 44.97M$ 36.71M$ 31.00M
Operating Income$ -110.38M$ -142.34M$ -202.26M$ -179.00M$ -94.27M
EBITDA$ -104.49M$ -133.64M$ -190.47M$ -142.25M$ -87.82M
Net Income$ -46.00M$ -60.64M$ -213.91M$ -164.83M$ -102.98M
Balance Sheet
Cash & Short-Term Investments$ 57.26M$ 80.93M$ 178.27M$ 305.74M$ 233.35M
Total Assets$ 144.22M$ 167.53M$ 294.30M$ 396.50M$ 328.83M
Total Debt$ 75.96M$ 88.59M$ 127.34M$ 74.98M$ 89.08M
Net Debt$ 18.70M$ 7.67M$ -50.92M$ -230.77M$ -144.28M
Total Liabilities$ 145.87M$ 165.94M$ 244.28M$ 170.63M$ 131.84M
Stockholders' Equity$ 22.74M$ 22.54M$ 41.72M$ 108.67M$ 100.34M
Cash Flow
Free Cash Flow$ -95.19M$ -136.32M$ -182.46M$ -132.89M$ -90.85M
Operating Cash Flow$ -80.19M$ -128.22M$ -179.40M$ -116.54M$ -83.68M
Investing Cash Flow$ -15.00M$ -2.10M$ -22.93M$ 40.51M$ -7.16M
Financing Cash Flow$ 70.64M$ 32.74M$ 75.32M$ 148.99M$ 172.41M
Currency in USD

Fortress Biotech Earnings and Revenue History

Fortress Biotech Debt to Assets

Fortress Biotech Cash Flow

Fortress Biotech Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis